Peter Hoogerbrugge

Calculated based on number of publications stored in Pure and citations from Scopus
1985 …2024

Research activity per year

Network

Dinko Valerio

  • King's College London
  • Crucell NV
  • Leiden University
  • Institute of Applied Radiobiology and Immunology TNO
  • Netherlands Organisation for Applied Scientific Research
  • Salk Institute for Biological Studies

External person

G. J. Adema

  • Radboud University Nijmegen

External person

Dirk W. Van Bekkum

  • Netherlands Organisation for Applied Scientific Research
  • Erasmus University Rotterdam
  • Leiden University
  • University of North Carolina at Chapel Hill
  • Crucell NV

External person

Annelies M.C. Mavinkurve-Groothuis

  • Radboud University Nijmegen
  • Princess Máxima Center for Pediatric Oncology
  • Utrecht University

External person

J. M. Vossen

  • Leiden University
  • Subdivision Bone Marrow Transplant.

External person

B. J.H.M. Poorthuis

  • Leiden University
  • University of North Carolina at Chapel Hill
  • Netherlands Organisation for Applied Scientific Research

External person

J. F.M. Jacobs

  • Radboud University Nijmegen

External person

R. M. Egeler

  • Leiden University
  • University of Toronto
  • Scientific Member of the Steering Committee
  • Dutch Childhood Oncology Group
  • Erasmus University Rotterdam

External person

Marc Bierings

  • Utrecht University
  • Princess Máxima Center for Pediatric Oncology
  • Dutch Childhood Oncology Group
  • Department of Pediatric Stem Cell Transplantation
  • University of Amsterdam

External person

J. J. Groot-Loonen

  • Radboud University Nijmegen

External person

Michiel Kroesen

  • Radboud University Nijmegen
  • Erasmus University Rotterdam
  • Holland Proton Therapy Center

External person

Theo J.C. Van Berkel

  • Leiden University

External person

Gerard Wagemaker

  • Netherlands Organisation for Applied Scientific Research
  • Erasmus University Rotterdam
  • Leiden University

External person

Jos PM Bökkerink

  • Dutch Childhood Oncology Group
  • Radboud University Nijmegen

External person

Nicole Herijgers

  • Leiden University

External person

Miranda Van Eck

  • Leiden University

External person

H. W.B. Schreuder

  • Radboud University Nijmegen
  • Dutch Orthopaedic Society

External person

Reinoud J.B.J. Gemke

  • VU University Medical Center

External person

T. Révész

  • Utrecht University
  • Women's and Children's Hospital Adelaide
  • University of Adelaide

External person

Ton Feuth

  • Radboud University Nijmegen

External person

V. W. Van Beusechem

  • King's College London
  • VU University Medical Center
  • Crucell NV
  • Institute of Applied Radiobiology and Immunology TNO

External person

Auke Beishuizen

  • Erasmus University Rotterdam
  • Princess Máxima Center for Pediatric Oncology
  • Dutch Gynecological Oncology Group

External person

Eveline S.J.M. De Bont

  • University of Groningen
  • Dutch Childhood Oncology Group

External person

Anjo J. Veerman

  • Dutch Childhood Oncology Group
  • VU University Medical Center
  • Dutch Childhood Leukemia Study Group
  • Juliana Children's Hospital
  • Ziekenhuis St. Joannes de Deo
  • Vrije Universiteit Amsterdam
  • Amsterdam University Medical Center (UMC)
  • Erasmus University Medical Center
  • Erasmus University Rotterdam
  • Nicolaus Copernicus University in Toruń
  • Dutch Childhood Leukaemia Study Group

External person

I. J.M. De Vries

  • Radboud University Nijmegen

External person

O. F. Brouwer

  • Leiden University
  • University of Groningen

External person

C. G. Figdor

  • Radboud University Nijmegen
  • Netherlands Cancer Institute

External person

Ingrid C. Brok

  • Radboud University Nijmegen

External person

Hester A. de Groot-Kruseman

  • Dutch Childhood Oncology Group
  • Dutch Gynecological Oncology Group
  • Princess Máxima Center for Pediatric Oncology
  • Australian and New Zealand Children's Haematology and Oncology Study Group
  • DCOG

External person

Kiek Tates

  • Tilburg University
  • Netherlands Institute for Health Services Research
  • Utrecht University

External person

Martijn H. Den Brok

  • Radboud University Nijmegen

External person

Jacques J.M. Van Dongen

  • Departments of Immunology
  • Erasmus University Rotterdam
  • Leiden University

External person

Simone M. Sint Nicolaas

  • Radboud University Nijmegen

External person

D. Maroeska W.M. Te Loo

  • Radboud University Nijmegen

External person

Antonie H.M. Taminiau

  • Leiden University

External person

Marieke Zwaanswijk

  • Netherlands Institute for Health Services Research

External person

Abraham Bout

  • Crucell NV
  • Leiden University

External person

Elisabeth R. van Wering

  • Dutch Childhood Oncology Group
  • Dutch Childhood Leukemia Study Group
  • VU University Medical Center
  • Juliana Children's Hospital
  • DCOG
  • Vrije Universiteit Amsterdam
  • Erasmus University Rotterdam
  • Stitching Kinderoncologie Nederland
  • Dutch Childhood Leukaemia Study Group

External person

Livia Kapusta

  • Radboud University Nijmegen
  • Tel Aviv University
  • Edith Wolfson Medical Center Israel

External person

Melissa Wassink

  • Radboud University Nijmegen

External person

H. N. Caron

  • University of Amsterdam
  • F. Hoffmann-La Roche AG
  • Amsterdam University Medical Center (UMC)
  • Individualized Therapies for Children with Cancer Study Group
  • Cochrane Childhood Cancer Group
  • Université Paris-Saclay
  • Stichting Kinderoncologie Nederland
  • Kids Cancer Kinome Consortium
  • Dutch Childhood Oncology Group

External person

Hendrik M. Koopman

  • Leiden University
  • University of Amsterdam

External person

Willem A. Kamps

  • University of Groningen
  • Dutch Childhood Oncology Group
  • UMC Groningen
  • Dutch Childhood Leukaemia Study Group
  • Dutch Childhood Leukemia Study Group

External person

Louis Boon

  • Bioceros
  • Utrecht University
  • EPIRUS Biopharmaceuticals Netherlands BV
  • Polpharma Biologics Utrecht

External person

A. Fischer

  • Leiden University
  • Université Paris Cité
  • College de France
  • Paris Descartes-Sorbonne Paris Cité University

External person

Cees J.J. Avezaat

  • Erasmus University Rotterdam

External person

M. Havenga

  • Leiden University

External person

Paul E. Verweij

  • Radboud University Nijmegen
  • Canisius Wilhelmina Hospital
  • Nijmegen Institute for Infection
  • National Institute of Public Health and the Environment
  • Department of Medical Microbiology
  • ESCMID Fungal Infection Study Group (EFISG)
  • European Confederation of Medical Mycology (ECMM)

External person

Sandra Van Dulmen

  • Netherlands Institute for Health Services Research
  • University of South-Eastern Norway
  • Radboud University Nijmegen

External person

Pieter H.E. Groot

  • GlaxoSmithKline

External person

Christianne M. Verhaak

  • Radboud University Nijmegen

External person

H. H.G. Van Es

  • InlmGene BV
  • Crucell NV
  • Leiden University

External person

Henk van den Berg

  • Dutch Childhood Oncology Group
  • University of Amsterdam
  • Amsterdam University Medical Center (UMC)
  • Dutch Childhood Leukemia Study Group

External person

Arnaud J.P.E. Vincent

  • Erasmus University Rotterdam

External person

Anthony V. Moorman

  • Newcastle University
  • University of Southampton

External person

Maria Del C. Esandi

  • Leiden University

External person

Rosemary Sutton

  • University of New South Wales
  • Sydney Children's Hospital
  • Children's Cancer Institute Australia

External person

Shekhar Krishnan

  • Tata Medical Center
  • University of Manchester
  • Tata Translational Cancer Research Centre
  • Paediatric Oncology

External person

Ronney De Abreu

  • Radboud University Nijmegen

External person

Milanthy S. Pourier

  • Radboud University Nijmegen

External person

Jakob K. Anninga

  • Leiden University
  • Princess Máxima Center for Pediatric Oncology
  • Radboud University Nijmegen
  • University of Amsterdam

External person

Peter A.E. Sillevis Smitt

  • Erasmus University Rotterdam
  • Erasmus University Medical Center

External person

Vincent H.J. van der Velden

  • Erasmus University Rotterdam
  • Dutch Childhood Oncology Group

External person

Vaskar Saha

  • Tata Medical Center
  • University of Manchester
  • Tata Translational Cancer Research Centre
  • Children’s Cancer and Leukaemia Group (CCLG)
  • Paediatric Oncology
  • Manchester University NHS Foundation Trust
  • Royal Manchester Children’s Hospital

External person

Thea P.M. Vliet Vlieland

  • Leiden University
  • Quality + Research
  • Hilversum and 6Flevo Hospital
  • Rijnland Rehabilitation Center

External person

Gerard R. Schaap

  • Amsterdam University Medical Center (UMC)
  • University of Amsterdam
  • Dutch Orthopaedic Society

External person

Connie Brouwer

  • Radboud University Nijmegen

External person

A. Hagenbeek

  • Utrecht University
  • University of Amsterdam
  • Netherlands Organisation for Applied Scientific Research
  • Erasmus University Rotterdam

External person

P. G. Coulie

  • Université catholique de Louvain

External person

Frans J.M. Trijbels

  • Radboud University Nijmegen

External person

Melanie M. Hagleitner

  • Princess Máxima Center for Pediatric Oncology
  • Radboud University Nijmegen

External person

Maartje S. Gordijn

  • VU University Medical Center

External person

Kinuko Suzuki

  • University of North Carolina at Chapel Hill

External person

A. E. Donker

  • Leiden University
  • Radboud University Nijmegen

External person

W. Peter Bekkering

  • Leiden University
  • Amsterdam University Medical Center (UMC)

External person

Adilia Warris

  • Radboud University Nijmegen
  • University of Exeter
  • University of Aberdeen
  • European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group (EFISG)
  • European Confederation of Medical Mycology (ECMM)
  • ESCMID Fungal Infection Study Group (EFISG)
  • University of Groningen

External person

Charles Vecht

  • Erasmus University Rotterdam
  • Haaglanden Medisch Centrum

External person

Jozien M. Bensing

  • Netherlands Institute for Health Services Research
  • Utrecht University
  • Erasmus University Rotterdam

External person

Chris de Korte

  • Schneider Childrens Medical Center Israel
  • Radboud University Nijmegen

External person

Catriona Parker

  • University of Manchester
  • Manchester University NHS Foundation Trust
  • Royal Manchester Children’s Hospital

External person

Christina Hulsbergen-Van De Kaa

  • Radboud University Nijmegen
  • Laboratory of Pathology East Netherlands (LABPON)

External person

Erik H.J.G. Aarntzen

  • Radboud University Nijmegen

External person

G. Morgan

  • King's College London
  • University College London

External person

A. Masurekar

  • University of Manchester
  • Manchester University NHS Foundation Trust

External person

Nigel J. Pearce

  • GlaxoSmithKline

External person

R. Vogels

  • Leiden University
  • Crucell NV

External person

L. D. Fairbanks

  • King's College London

External person

P. D. Maaswinkel-Mooij

  • Leiden University

External person

Oliver M. Grauer

  • University of Regensburg
  • Radboud University Nijmegen
  • University of Münster

External person

V. Engelen

  • University of Amsterdam
  • Dutch Society for Psychosocial Oncology (NVPO)

External person

Patricia G.J.H. Ter Riet

  • Radboud University Nijmegen

External person

R. G.M. Bredius

  • Leiden University

External person

Renske J.E. van den Bijgaart

  • Radboud University Nijmegen

External person

Marieke J.H. Coenen

  • Radboud University Nijmegen

External person

Francis Brasseur

  • Ludwig Institute for Cancer Research
  • Wellcome Sanger Institute

External person

Jenneke J. Keizer-Garritsen

  • Radboud University Nijmegen

External person

Daphne Reijnen

  • Radboud University Nijmegen

External person

Anton C.M. Martens

  • Utrecht University
  • VU University Medical Center
  • Netherlands Organisation for Applied Scientific Research

External person

Uta Flucke

  • Radboud University Nijmegen
  • University of Münster
  • Utrecht University
  • Princess Máxima Center for Pediatric Oncology

External person

N. M. Wulffraat

  • Utrecht University

External person

Antoinette Y.N. Schouten-van Meeteren

  • Princess Máxima Center for Pediatric Oncology
  • University of Amsterdam
  • VU University Medical Center
  • Dutch Childhood Oncology Group
  • Amsterdam University Medical Center (UMC)

External person

Valerie De Haas

  • Dutch Childhood Oncology Group
  • Princess Máxima Center for Pediatric Oncology
  • Stichting Kinderoncologie Nederland
  • VU University Medical Center
  • Clinical laboratory
  • University of Amsterdam
  • Dutch Gynecological Oncology Group
  • Australian and New Zealand Children's Haematology and Oncology Study Group
  • DCOG

External person

Inna Armandari

  • Gadjah Mada University
  • University of Groningen
  • Radboud University Nijmegen

External person

Esther van den Bergh

  • Princess Máxima Center for Pediatric Oncology
  • Radboud University Nijmegen

External person

S. Love

  • University of Oxford

External person

Mariël L. te Winkel

  • Erasmus University Rotterdam
  • Princess Máxima Center for Pediatric Oncology

External person

Jan A. Leeuw

  • Dutch Childhood Oncology Group
  • University of Groningen

External person

Cobi J. Heijnen

  • Amsterdam University Medical Center (UMC)
  • ETZ Elisabeth
  • Utrecht University
  • Rijnstate Hospital
  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

H. B. Gaspar

  • King's College London
  • University College London

External person

Marissa A.H. den Hoed

  • Erasmus University Rotterdam
  • Princess Máxima Center for Pediatric Oncology

External person

Marrie CA Bruin

  • Dutch Childhood Oncology Group
  • Utrecht University

External person

Karen A. Marcus

  • Radboud University Nijmegen

External person

Frank W. Preijers

  • Radboud University Nijmegen

External person

Eveline S.J.M. de Bont

  • University Medical Center Groningen

External person

A. Moseley

  • King's College London
  • Applied Immune Sciences, Inc.

External person

Mandy W.M.M. Van De Rakt

  • Radboud University Nijmegen

External person

Jeremy Hancock

  • Southmead Hospital Bristol
  • Children’s Cancer and Leukaemia Group (CCLG)
  • North Bristol NHS Trust

External person

R. J. Levinsky

  • King's College London
  • University College London

External person

Mats Heyman

  • Karolinska Institutet

External person

A. H. Zwinderman

  • University of Amsterdam
  • Leiden University
  • Amsterdam University Medical Center (UMC)
  • Karolinska Institutet

External person

R. Fisher

  • Crucell NV

External person

Lotte Haverman

  • University of Amsterdam
  • Amsterdam University Medical Center (UMC)
  • Amsterdam UMC
  • St. Jude Children Research Hospital

External person

Pancras C.W. Hogendoorn

  • Leiden University

External person

Juus L. Noteboom

  • Leiden University

External person

Kunihiko Suzuki

  • University of North Carolina at Chapel Hill

External person

P. Brons

  • Radboud University Nijmegen
  • Hemophilia Treatment Center

External person

Christian Büll

  • Radboud University Nijmegen

External person

Anna Østergaard

  • University Medical Center Utrecht
  • University of Copenhagen
  • Princess Máxima Center for Pediatric Oncology

External person

Ellen Van Der Schoot

  • Sanquin Blood Supply Foundation
  • University of Amsterdam

External person

Louise Bellersen

  • Radboud University Nijmegen

External person

Paul R. Gielen

  • Radboud University Nijmegen

External person

Jaap Huisman

  • Utrecht University
  • VU University Medical Center
  • Princess Máxima Center for Pediatric Oncology
  • University of Amsterdam

External person

Thomas J. Boltje

  • Radboud University Nijmegen

External person

Xiao-Nan Li

  • Texas Children's Cancer Center

External person

Bertil Johansson

  • University of Southern Denmark
  • Scania Regional Council
  • Lund University

External person

O. Ringden

  • Karolinska Institutet

External person

J. Gert Van Enk

  • Gelderland Valley Hospital

External person

B. Bakker

  • Leiden University

External person

Paula Schomberg

  • Mayo Clinic Rochester, MN

External person

Eric Braakman

  • Erasmus University Rotterdam
  • Netherlands Organisation for Applied Scientific Research
  • Heidelberg University 

External person

Andries H. Mulder

  • Netherlands Organisation for Applied Scientific Research

External person

David M. Burger

  • Radboud University Nijmegen
  • Nijmegen Institute for Infection
  • University of Groningen

External person

Maarten J.D. van Tol

  • Leiden University

External person

Anna van der Does-van den Berg

  • Dutch Childhood Oncology Group
  • Centraal Bureau SNWLK
  • Vrije Universiteit Amsterdam
  • Dutch Childhood Leukemia Study Group
  • SKION
  • DCOG

External person

Dimitris Grivas

  • Utrecht University

External person

Erica L.T. Van Den Akker

  • Erasmus University Rotterdam
  • Princess Máxima Center for Pediatric Oncology

External person

M. J.F.J. Vernooij-Dassen

  • Radboud University Nijmegen

External person

Lucie Sramkova

  • Charles University

External person

Maaike A. van Hout-Kuijer

  • Radboud University Nijmegen

External person

F. Le Deist

  • Université Paris Cité

External person

V. Wagner

  • Gesellschaft für Biologische Analytik mbh

External person

Frank J.G. Scherpen

  • University of Groningen

External person

H. J. Van Der Woude

  • Leiden University

External person

H. Van Der Lelie

  • Amsterdam University Medical Center (UMC)

External person

Edo D. Elstak

  • Utrecht University

External person

Maaike W.G. Looman

  • Radboud University Nijmegen

External person

Judith W.M. Jeuken

  • Radboud University Nijmegen
  • Laboratory for Pathology and Medical Microbiology (PAMM)
  • Erasmus University Rotterdam

External person

C. Hardt

  • University of Duisburg-Essen

External person

Neyssa Marina

  • Stanford University

External person

Liesbeth van Emst

  • Radboud University Nijmegen

External person

Lya E. Van Die

  • Harbor Hospital

External person

H. A. Simmonds

  • King's College London

External person

C. C. van Leer-Buter

  • University of Groningen
  • Radboud University Nijmegen

External person

Hans Gelderblom

  • Leiden University
  • Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
  • Leiden UMC
  • Dutch SUTOX consortium

External person

Jan Boesen

  • Leiden University

External person

Arend H. Sikkema

  • University of Groningen

External person

S. A. Joosten

  • Erasmus University Rotterdam

External person

Dorine Bresters

  • Leiden University
  • Princess Máxima Center for Pediatric Oncology
  • Dutch Childhood Oncology Group
  • Utrecht University
  • VU University Medical Center
  • Erasmus University Rotterdam
  • Willem-Alexander Children's Hospital
  • Center for Pediatric Oncology

External person

Kalijn F. Bol

  • Radboud University Nijmegen

External person

F. Verduyn-Lunel

  • Utrecht University
  • Radboud University Nijmegen

External person

M. H. Lequin

  • Erasmus University Rotterdam
  • Utrecht University
  • Princess Máxima Center for Pediatric Oncology

External person

I. Jolanda M. Vries

  • Radboud University Nijmegen

External person

S. B. Detmar

  • Netherlands Organisation for Applied Scientific Research

External person

Edwin Sonneveld

  • Dutch Childhood Oncology Group
  • Erasmus University Rotterdam
  • Princess Máxima Center for Pediatric Oncology
  • DCOG
  • Dutch Gynecological Oncology Group

External person

H. Van Den Berg

  • University of Amsterdam

External person

Albert J. Idema

  • Radboud University Nijmegen

External person

P. Chiusolo

  • Catholic University of the Sacred Heart

External person

P. Bordigoni

  • CHU de Nancy

External person

C. H.M. Van Den Ende

  • Radboud University Nijmegen

External person

Philip J. Ancliff

  • University College London

External person

Suzan Dijkstra

  • Princess Máxima Center for Pediatric Oncology

External person

Roel Otten

  • Netherlands Institute for Health Services Research

External person

Jacqueline J. Loonen

  • Radboud University Nijmegen
  • Utrecht University
  • Center for Pediatric Oncology

External person

James Meyer

  • University of Pennsylvania

External person

Heribert Jürgens

  • University of Münster
  • Klin./Poliklin. fur Kinderheilk.
  • Justus Liebig University Giessen
  • Coordinating Center for Clinical Trials

External person

Dexi Liu

  • University of Pittsburgh

External person

S. Pillen

  • Kempenhaeghe Epilepsy Centre
  • Radboud University Nijmegen

External person

Tom Böhling

  • University of Helsinki

External person

Anne O'Meara

  • Our Lady's Hospital for Sick Children
  • Lady's Children Hospital
  • Autonomous University of Barcelona
  • Royal Marsden NHS Foundation Trust
  • Institute of Child Life and Health
  • Université Paris-Saclay
  • Hospital de Pediatría Prof. Dr. Juan P. Garrahan
  • University of Amsterdam

External person

Femke Verwer

  • Dutch Childhood Oncology Group

External person

Margret J.C. Tielemans

  • Netherlands Organisation for Applied Scientific Research

External person

Sofia Gameiro

  • Cardiff University

External person

M. J. Willemse

  • Erasmus University Rotterdam

External person

Claudia Deffenbaugh

  • Lucille Packard Children's Hospital

External person

Catharina Dhooge

  • Ghent University

External person

Winette T.A. van der Graaf

  • Netherlands Cancer Institute
  • Erasmus University Rotterdam
  • Radboud University Nijmegen
  • Institute of Cancer Research
  • Antoni van Leeuwenhoek Hospital
  • University of Groningen

External person

José A.E. Custers

  • Radboud University Nijmegen

External person

Joep M. Galama

  • Radboud University Nijmegen
  • Leiden University

External person

Christiane Chen-Santel

  • Charité – Universitätsmedizin Berlin
  • University of Rostock

External person

Mónica López-Duarte

  • Hospital Universitario Marques de Valdecilla

External person

Joachim Gerß

  • University of Münster

External person

Jacqueline Cloos

  • Amsterdam UMC

External person

Daniel Baumhoer

  • University of Oslo
  • University of Basel

External person

F. H.J. Claas

  • Leiden University

External person

G. Souillet

  • Hôpital Debrousse

External person

A. Ng

  • The Children's Hospital at Westmead

External person

Ajay Vora

  • Sheffield Children's NHS Foundation Trust
  • University College London
  • United Kingdom Children Cancer Study Group
  • University of Milan - Bicocca
  • University of Manchester
  • University of Birmingham
  • University of Sheffield
  • UKCCSG

External person

Maureen M. O’Brien

  • University of Cincinnati

External person

Leonard J. Dooren

  • Leiden University

External person

L. F. Verdonck

  • Utrecht University

External person

Glyn Elwyn

  • Dartmouth College
  • Cardiff University
  • Radboud University Nijmegen

External person

Mervi Taskinen

  • University of Helsinki

External person

Rosalin M. van Schie

  • Radboud University Nijmegen

External person

Mandy W.M.M. Rakt

  • Radboud University Nijmegen

External person

Menno de Winther

  • Ludwig Maximilian University of Munich
  • University of Amsterdam
  • Leiden University
  • German Centre for Cardiovascular Research
  • Amsterdam University Medical Center (UMC)

External person

L. B.S. Gelinck

  • Haaglanden Medisch Centrum
  • Leiden University

External person

Arno Van Heijst

  • Radboud University Nijmegen

External person

Judith R. Ladestein

  • Novartis Pharma BV

External person

Stefanie Groeneveld-Krentz

  • Charité – Universitätsmedizin Berlin

External person

Ramon O. Tak

  • Radboud University Nijmegen

External person

D. Frappaz

  • Hôpital Nord, CHU de Saint-Étienne
  • Centre Léon Bérard

External person

Peter Van Kerkhof

  • Utrecht University

External person

Cornelis Punt

  • Radboud University Nijmegen
  • Amsterdam University Medical Center (UMC)
  • Aarhus University
  • University of Amsterdam
  • Utrecht University
  • Charité – Universitätsmedizin Berlin
  • University of Birmingham
  • Heidelberg University 

External person

Carol Morris

  • Memorial Sloan-Kettering Cancer Center

External person

Ram Suppiah

  • Women's and Children's Hospital Adelaide
  • Australian and New Zealand Children's Haematology and Oncology Study Group
  • Mater Group
  • Oncology Study Group
  • ANZCHOG

External person

Gabriele Calaminus

  • International Society of Paediatric Oncology (SIOP)
  • University of Münster
  • University of Bonn
  • University Hospital Bonn

External person

Anna C.I. Boullart

  • Radboud University Nijmegen

External person

Jeremy D. Rubinstein

  • University of Cincinnati

External person

Jaap Jan Boelens

  • Utrecht University
  • Memorial Sloan-Kettering Cancer Center
  • Princess Máxima Center for Pediatric Oncology
  • University College London
  • Weill Cornell Medicine
  • Cornell University
  • Laboratory of Translational Immunology

External person

Peter Van der Sluijs

  • Utrecht University

External person

Janneke Noordman

  • Netherlands Institute for Health Services Research

External person

Marleen Ansems

  • Radboud University Nijmegen

External person

J. J. van Rood

  • Europdonor Foundation
  • Leiden University

External person

Arwen J. Sprij

  • Leiden University

External person

Rajaram Nagarajan

  • Cincinnati Children's Hospital Medical Center

External person

Arend Von Stackelberg

  • Charité – Universitätsmedizin Berlin
  • Berlin-Frankfurt-Muenster (BFM)
  • University College London
  • Humboldt University of Berlin
  • BFM-ALL REZ Group
  • National Center for Tumor Diseases (NCT) Network
  • German Cancer Research Center

External person

E. J.A. Gerritsen

  • Leiden University

External person

T. Law

  • University of New South Wales
  • Children's Cancer Institute Australia

External person

Lisa A. Teot

  • Harvard University

External person

M. J. Driesse

  • Erasmus University Rotterdam

External person

Gordana Jovic

  • Medical Research Council
  • University College London

External person

Veerle J. Ruijters

  • Princess Máxima Center for Pediatric Oncology
  • University Medical Center Utrecht

External person

Ching C. Lau

  • Institut Curie
  • Harvard University
  • Baylor College of Medicine
  • St. Jude Children Research Hospital
  • Dana-Farber Cancer Institute
  • Amsterdam University Medical Center (UMC)
  • Broad Institute
  • University of Washington
  • Johns Hopkins University

External person

R. A. Wevers

  • Radboud University Nijmegen
  • VU University Medical Center
  • Department Laboratory Medicine

External person

M. Zimmermann

  • Hannover Medical School
  • Berlin-Frankfurt-Muenster (BFM)
  • Erasmus University Rotterdam
  • Charles University
  • BFM-AML Studien Zentrale

External person

Rob Ruijtenbeek

  • PamGene International B.V.

External person

Ilse M.P. Arts

  • Radboud University Nijmegen

External person

C. H. Skeoch

  • NHS Greater Glasgow and Clyde

External person

Blanca Scheijen

  • Radboud University Nijmegen

External person

T. Van Achterberg

  • Radboud University Nijmegen

External person

Barbara De Moerloose

  • Ghent University
  • Cancer Research Institute Ghent (CRIG)
  • European Organisation for Research and Treatment of Cancer Data Center
  • Belgian Society of Paediatric Haematology Oncology

External person

J. M.J. Theunissen

  • Radboud University Nijmegen

External person

Gert Weijers

  • Radboud University Nijmegen

External person

Suzanne J.A. Korporaal

  • Leiden University

External person

Gertjan J. L. Kaspers

  • Amsterdam University Medical Centers

External person

R. G. Nelissen

  • Leiden University
  • Delft University of Technology

External person

Zsuzsanna Pápai

  • National Medical Center Budapest

External person

Matilda Degn

  • University of Copenhagen

External person

M. Debree

  • Université Paris Cité

External person

C. Ciria

  • University of Oxford

External person

Kiki Tesselaar

  • Utrecht University

External person

H. van der Putten

  • Salk Institute for Biological Studies

External person

Franco Locatelli

  • University of Pavia
  • IRCCS Ospedale pediatrico Bambino Gesù - Roma
  • IRCCS Fondazione Policlinico San Matteo - Pavia
  • University of Rome La Sapienza
  • Heinrich Heine University Düsseldorf
  • University of Milan - Bicocca
  • Childhood AML Working Party, AIEOP
  • Catholic University of the Sacred Heart

External person

Monique van Scherpenzeel

  • Radboud University Nijmegen

External person

Peter Reichardt

  • HELIOS Clinic Berlin Buch
  • Klinik für Interdisziplinäre Onkologie

External person

Mirjam Van Der Burg

  • Erasmus University Rotterdam

External person

J. Hermans

  • Leiden University

External person

A. Vd Does van den Berg

  • Leiden University

External person

Philip J. Darbyshire

  • Birmingham Women's and Children's NHS Foundation Trust

External person

Jack J.H. Bleesing

  • Leiden University

External person

Murray D. Norris

  • University of New South Wales
  • Children's Cancer Institute Australia

External person

Andrea W.M. Evers

  • Leiden University
  • Radboud University Nijmegen

External person

Nicole C.A.J. van de Kar

  • Radboud University Nijmegen

External person

Henricus G.F. Brouwer

  • Elkerliek Ziekenhuis

External person

Bernadette Brennan

  • Royal Manchester Children’s Hospital

External person

Richard Gorlick

  • Montefiore Health System

External person

M. B.A. Heemskerk

  • Europdonor Foundation
  • Leiden University

External person

Piet J. Boender

  • PamGene International B.V.

External person

Yvonne Kooy

  • Leiden University

External person

A. E. Romme

  • Leiden University

External person

Esther Meijer-Van Den Bergh

  • Radboud University Nijmegen

External person

Michelle Haber

  • University of New South Wales
  • Children's Cancer Institute Australia

External person

F. G.J. Calkoen

  • Leiden University
  • Princess Máxima Center for Pediatric Oncology

External person

Sander H. Diks

  • University of Groningen

External person

Donato Gemmati

  • University of Ferrara

External person

Solveig Hafsteinsdottir

  • Landspitali University Hospital

External person

Ad Geurts Van Kessel

  • Radboud University Nijmegen
  • Utrecht University

External person

M. Bron

  • Erasmus University Rotterdam

External person

Carin M. Damen-Korbijn

  • Dutch Childhood Oncology Group

External person

Peter M. van de Ven

  • VU University Medical Center

External person

M. Luisa Mearin

  • Leiden University

External person

J. Vermeulen

  • Erasmus University Rotterdam

External person

Jan C. Roos

  • VU University Medical Center

External person

J. L. Perignon

  • Université Paris Cité

External person

Victor Van Beuseehem

  • Leiden University

External person

I. C.M. Slaper-Cortenbach

  • Sanquin Blood Supply Foundation
  • University of Amsterdam
  • Utrecht University

External person

B. Vormoor

  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Princess Máxima Center for Pediatric Oncology

External person

C. Weemaes

  • Radboud University Nijmegen

External person

P. Kapaun

  • University of Hamburg

External person

Aad Verrips

  • Radboud University Nijmegen
  • VU University Medical Center
  • Canisius Wilhelmina Hospital

External person

Robert C. Trueworthy

  • University of Kansas

External person

Alexander M.M. Arons

  • Novartis Pharma BV

External person

G. V. Someren

  • Leiden University

External person

Michel A.A.P. Willemsen

  • Radboud University Nijmegen

External person

Akira Kondo

  • University of North Carolina at Chapel Hill

External person

Frits Koning

  • Leiden University

External person

Julie Irving

  • Newcastle University

External person

Kim R. Kampen

  • University of Groningen

External person

Jeremy Whelan

  • University College London

External person

Ed J. Kuijper

  • Leiden University
  • National Institute of Public Health and the Environment

External person

Arjan C. Lankester

  • Leiden University

External person

Trude Butterfass-Bahloul

  • University of Münster

External person

H. P.E. Borst

  • University of Amsterdam

External person

Per Ulf Tunn

  • Fresenius AG

External person

Susan R. Rheingold

  • University of Pennsylvania

External person

Bert A. van der Reijden

  • Radboud University Nijmegen

External person

C. Fong

  • University of Manchester

External person

F. M. Boneri

  • Salk Institute for Biological Studies

External person

Margreet A. Veening

  • Vrije Universiteit Amsterdam
  • Princess Máxima Center for Pediatric Oncology
  • University of Amsterdam
  • VU University Medical Center
  • Amsterdam University Medical Center (UMC)

External person

A. Derk Jan Ten Harkel

  • Leiden University

External person

Andishe Attarbaschi

  • Medical University of Vienna
  • BFM
  • Berlin-Frankfurt-Münster Study Group
  • Children's Cancer Research Institute

External person

B. Zeller

  • University of Oslo
  • Nordic Society of Pediatric Haematology and Oncology

External person

Mark Bernstein

  • Dalhousie University

External person

J. J.P. Van De Kamp

  • Leiden University

External person

Rob S. Binnendijk

  • National Institute of Public Health and the Environment

External person

K. Suzuki

  • Netherlands Organisation for Applied Scientific Research

External person

S. Ferencik

  • University of Duisburg-Essen

External person

Frederick W. Thielen

  • Erasmus University Rotterdam

External person

K. L. Liem

  • Radboud University Nijmegen

External person

Stephane Blanche

  • Université Paris Cité
  • Paris Descartes-Sorbonne Paris Cité University

External person

Martin Vidgeon-Hart

  • GlaxoSmithKline

External person

A. J.J. Reuser

  • Erasmus University Rotterdam

External person

Milensu Shanyinde

  • University of Oxford

External person

Imelda J.M. De Groot

  • Radboud University Nijmegen

External person

B. Roberts

  • Genzyme Corporation

External person

A. T. Van Den Ploeg

  • Erasmus University Rotterdam

External person

Michel Wensing

  • Radboud University Nijmegen

External person

Mikael Eriksson

  • Lund University

External person

Knut Helmke

  • University of Hamburg

External person

Marten H. Hofker

  • Leiden University

External person

Kjeld Schmiegelow

  • University of Copenhagen
  • VU University Medical Center
  • New York University
  • Nordic Society of Pediatric Haematology and Oncology

External person

Peter Bader

  • Hospital for Children and Adolescents
  • Goethe University Frankfurt
  • University of Tübingen

External person

Annet Simons

  • Radboud University Nijmegen

External person

Jeroen A.W.M. van der Laak

  • Radboud University Nijmegen
  • Linköping University

External person

Renate Kirschner-Schwabe

  • Charité – Universitätsmedizin Berlin
  • German Cancer Research Center
  • German Cancer Consortium (DKTK)

External person

Dorien Bresters

  • Dutch Childhood Oncology Group
  • Leiden University

External person

Krzysztof Kałwak

  • Wrocław Medical University

External person

J. J. Cornelissen

  • Erasmus University Rotterdam

External person